Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Active, not recruiting2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed240%

active_not_recruiting240%

terminated120%

Recent Activity

2 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

NCT05893498

terminated

FFR-CT to Detect the Absence of Hemodynamically Significant Lesions in Patients With High-risk Acute Coronary Syndrome

NCT04052763

active_not_recruiting

Clinical Trials (5)

Showing 5 of 5 trials

NCT05893498Not Applicable

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Active Not Recruiting

NCT04052763

FFR-CT to Detect the Absence of Hemodynamically Significant Lesions in Patients With High-risk Acute Coronary Syndrome

Terminated

NCT05648396

Japan FFRangio Clinical Outcomes Study

Active Not Recruiting

NCT03455244

Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease

Completed

NCT03226262

FFRangio Accuracy vs. Standard FFR

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5